Rain Therapeutics' Convertible Note Round

Rain Therapeutics raised a round of funding on December 13, 2017.

Rain Therapeutics is focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.…

Articles about Rain Therapeutics' Convertible Note Round: